{"abstract": "While his legacy and tenure are under pressure from Carl C. Icahn, no one expects Genzyme chief Henri A. Termeer to go easily, The New York Times reports.", "web_url": "https://dealbook.nytimes.com/2010/02/23/genzyme-chief-may-not-go-gently/", "snippet": "While his legacy and tenure are under pressure from Carl C. Icahn, no one expects Genzyme chief Henri A. Termeer to go easily, The New York Times reports.", "lead_paragraph": "In the biotechnology business, where executives or even entire companies can come and go in an instant, Henri A. Termeer has been a constant.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Genzyme Chief May Not Go Gently", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Genzyme Corp", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Relational Investors LLC", "rank": 2, "major": "N"}], "pub_date": "2010-02-23T09:28:51+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/0bf73d89-8aa7-5e0a-81e9-5dc5a24d82e6", "word_count": 1158, "uri": "nyt://article/0bf73d89-8aa7-5e0a-81e9-5dc5a24d82e6"}